-

Direct-to-Consumer Genetic Testing Market and Technology Research Report 2024-2029, Profiles of Major Players - Ancestry, 23andMe, MyHeritage, myDNA, Dante Labs, and Color Health - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Direct-to-Consumer Genetic Testing Market and Technologies" report has been added to ResearchAndMarkets.com's offering.

The Direct-to-Consumer Genetic Testing Market was valued at USD 2.3 billion in 2024, and is projected to reach USD 3.7 billion by 2029, rising at a CAGR of 10%.

For each segment, current products are identified for the base year of 2023, the current market size is measured and market drivers identified, forecasts are made for 2029, and the current market shares of companies are assessed.

The report analyzes the market for DTC genetic testing, offering a look at the competitive landscape and the leading companies' revenues, product portfolios and recent developments. The report analyzes trends and market dynamics, including drivers, limitations, challenges and opportunities. It assesses current and potential market size, in order to help industry executives make informed decisions about the production and licensing of goods and services. The study segments the market on the basis of segment/application type, such as ancestry, health and lifestyle.

Regional market analysis is provided for all the major segments. The report covers tests that are directly ordered by consumers and consumer-initiated, physician-monitored tests. The DTC genetic testing of animals is outside the scope of the report. Regional market analysis is provided for all the major segments, and this includes some country-level analysis.

This report reviews the main DTC genetic testing technologies, including next-generation sequencing (NGS) and genotyping microarrays.

The report includes:

  • 18 data tables and 27 additional tables
  • An overview of the global market and technologies for Direct-to-Consumer Genetic Testing
  • Analyses of the global market trends, with data from 2021-2023, estimates for 2024, and projections of compound annual growth rates (CAGRs) through 2029
  • Evaluation of the current market size and prospects for revenue growth, accompanied by a market share analysis by product type, and region
  • Forecast of future trends, including regulatory challenges, review of patents, ESG trends and emerging technologies
  • Market share analysis of the key companies in the industry and coverage of mergers & acquisitions, joint ventures, collaborations, partnerships and other strategies
  • Profiles of the major players, including: Ancestry, 23andMe, MyHeritage, myDNA, Dante Labs, and Color Health

Key Attributes:

Report Attribute Details
No. of Pages 84
Forecast Period 2024 - 2029
Estimated Market Value (USD) in 2024 $2.3 Billion
Forecasted Market Value (USD) by 2029 $3.7 Billion
Compound Annual Growth Rate 10.0%
Regions Covered Global



Key Topics Covered:

Chapter 1 Executive Summary

  • Market Outlook
  • Scope of Report
  • Market Summary

Chapter 2 Market Overview

  • Market Overview and Definitions
  • Genetic Testing
  • History of DTC Genetic Testing
  • Types of DTC Genetic Tests
  • Regulatory Framework
  • United States
  • Europe
  • Asia-Pacific

Chapter 3 Market Dynamics

  • Market Dynamics
  • Market Drivers
  • Dropping Cost of Genomic Sequencing
  • Aggressive Marketing
  • Pharmacogenomic Testing
  • Increasing Prevalence of Chronic Diseases
  • Increasing Awareness
  • Market Opportunities
  • Enhancing Patient-Physician Collaboration
  • Market Restraints
  • Inefficiencies of DTC Genetic Tests
  • Limited Insurance Coverage
  • Privacy Concerns
  • False Results
  • Costs of Increased Referrals
  • Market Challenges
  • Supply Chain Challenges
  • Data Management, Quality Control and Customer Service

Chapter 4 Emerging Technologies and Developments

  • Overview
  • Artificial Intelligence
  • WGS and WES
  • Blockchain Technology
  • Genomic Data in Drug Development

Chapter 5 DTC Genetic Testing Market

  • Segmentation Breakdown
  • Market Breakdown, by Product Type
  • Ancestry DTC Genetic Testing Market
  • Health DTC Genetic Testing Market
  • Lifestyle DTC Genetic Testing Market
  • Geographic Breakdown
  • Market Breakdown, by Region
  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Rest of the World

Chapter 6 Competitive Intelligence

  • Industry Scenario
  • Company Shares
  • Competitive Landscape

Chapter 7 Sustainability in the DTC Genetic Testing Industry: An ESG Perspective

  • Introduction to ESG
  • Environmental Performance
  • Social Performance
  • Governance Performance
  • Concluding Remarks

Chapter 8 Patent Analysis

Chapter 9 Appendix

Companies Featured

  • 23andMe Inc.
  • Ancestry
  • Color Health Inc.
  • Dante Labs Global
  • myDNA Life Australia Pty Ltd.
  • MyHeritage Ltd.
  • Privapath Diagnostics

For more information about this report visit https://www.researchandmarkets.com/r/9l9lec

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Research and Markets


Release Versions

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

More News From Research and Markets

ENT Disorder Treatment: Global Market Trends, Regional Outlook and Growth Forecast 2025-2032 - Surge in Reimbursement Approvals for Novel Biologics Treating Severe Allergic & Chronic Sinusitis - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "ENT Disorder Treatment Market - Global Forecast 2025-2032" report has been added to ResearchAndMarkets.com's offering. The ENT disorder treatment market is experiencing rapid transformation as organizations adopt new medical technologies and evolving care models to address complex clinical and operational challenges. Senior decision-makers are seeking strategies that enable both enhanced patient outcomes and sustainable organizational performance in this dynamic he...

Thyroid Eye Disease (TED) Treatments Market Nears $4.3 Billion by 2032: Emerging Small Molecule Therapies Targeting Orbital Fibroblasts Drive Revenue Growth - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Thyroid Eye Disease Treatments Market - Global Forecast 2025-2032" report has been added to ResearchAndMarkets.com's offering. The thyroid eye disease treatments market is undergoing substantial transformation, fueled by new therapies, advanced diagnostics, and evolving care pathways. As a complex autoimmune disorder, thyroid eye disease challenges health systems and presents significant opportunities for innovation and patient-centered solutions. Market Snapshot:...

Electric Vehicles Battery Recycling Market Trends and Competition Analysis, 2025-2032 - Investment in Direct Cathode Recycling Methods are Reducing Energy Consumption and Waste - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Electric Vehicles Battery Recycling Market - Global Forecast 2025-2032" report has been added to ResearchAndMarkets.com's offering. As stakeholders across the mobility sector pursue sustainability, the electric vehicles battery recycling market is quickly gaining prominence, driven by regulatory, economic, and technological imperatives. Senior decision-makers require actionable insights to navigate evolving policy, emerging partnerships, and investment priorities....
Back to Newsroom